Skip to main content

Advertisement

SpringerLink
Log in

Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

Patients with sporadic medullary thyroid carcinoma (MTC) have a variable clinical course. Our aim was to analyse the reduction of tumour markers after thyroidectomy with meticulous dissection and relate it to clinical outcome.

Materials and methods

Twenty consecutive patients with palpable sporadic MTC underwent thyroidectomy with central and uni- or bilateral modified radical neck dissection; three were subjected to mediastinal dissection. Basal (b-) and stimulated (s-) calcitonin (CT) and carcinoembryonic antigen (CEA)-levels were measured before and 6–8 weeks after primary surgery, and the reduction of these tumour markers was determined.

Results

Median CT (b- and s-) were markedly reduced after surgery (98.5% and 99.1%, respectively), and CEA decreased 11 times. CT (b-) fell >99% in seven patients after surgery; in these and four additional patients, CT (s-) showed a similar reduction. During follow-up (median 52.5 months), two patients (stages IV B and C) died of MTC; they had <95% reduction of CT. Four patients (stage IV A) are alive with verified metastases. Eight patients (one stage III, seven stage IV A) are alive with hypercalcitoninemia. Five stages I–III patients and one stage IV A patient are disease-free.

Conclusions

Thyroidectomy and meticulous dissection caused a pronounced reduction of tumour markers. A postoperative reduction of CT (s-) ≥97% seems to be associated with less aggressive clinical course, while CEA had lower predictive value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 31:1960–1965

    Article  PubMed  Google Scholar 

  2. Osamura RY, Yasuda O, Kawakami T, Itoh Y, Inada K, Kakudo K (1997) Immunoelectron microscopic demonstration of regulated pathway for calcitonin and constitutive pathway for carcinoembryonic antigen in the same cells of human medullary carcinomas of thyroid glands. Mod Pathol 10:7–11

    PubMed  CAS  Google Scholar 

  3. Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, Busnardo B (1998) Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid 8:517–523

    Article  PubMed  CAS  Google Scholar 

  4. Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS, van Heerden JA, Sizemore GW, Hay ID (1992) Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 67:934–940

    PubMed  CAS  Google Scholar 

  5. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, Schlumberger M, Bigorgne JC, Dumontier P, Leclerc L, Corcuff B, Guilhem I (1998) Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’étude des tumeurs à calcitonine. Clin Endocrinol 48:265–273

    Article  CAS  Google Scholar 

  6. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Hölzer S (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89:202–217

    Article  PubMed  CAS  Google Scholar 

  7. Moley JF, Fialkowski EA (2007) Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World J Surg 31:946–956

    Article  PubMed  Google Scholar 

  8. Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887

    Article  PubMed  CAS  Google Scholar 

  9. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H (2000) Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88:1909–1915

    Article  PubMed  CAS  Google Scholar 

  10. Weber T, Schilling T, Frank-Raue K, Colombo-Benkmann M, Hinz U, Ziegler R, Klar E (2001) Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 130:1044–1049

    Article  PubMed  CAS  Google Scholar 

  11. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070–2075

    Article  PubMed  CAS  Google Scholar 

  12. Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230:697–707

    Article  PubMed  CAS  Google Scholar 

  13. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22:562–567

    Article  PubMed  CAS  Google Scholar 

  14. Pelizzo MR, Boschin IM, Bernante P, Toniato A, Piotto A, Pagetta C, Nibale O, Rampin L, Muzzio PC, Rubello D (2007) Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. Eur J Surg Oncol 33:493–497

    Article  PubMed  CAS  Google Scholar 

  15. Tisell LE, Oden A, Muth A, Altiparmak G, Mölne J, Ahlman H, Nilsson O (2003) The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer 89:2093–2097

    Article  PubMed  CAS  Google Scholar 

  16. Laure Giraudet A, Al Ghulzan A, Aupérin A, Leboulleux S, Chehboun A, Troalen F, Dromain C, Lumbroso J, Baudin E, Schlumberger M (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 158:239–246

    Article  PubMed  CAS  Google Scholar 

  17. TNM classification of malignant tumours (2002) Wiley-Liss, New York

  18. Busnardo B, Girelli ME, Simioni N, Nacamulli D, Busetto E (1984) Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer 53:278–285

    Article  PubMed  CAS  Google Scholar 

  19. Wells SA Jr, Haagensen DE Jr, Linehan WM, Farrell RE, Dilley WG (1978) The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer 42:1498–1503

    Article  PubMed  CAS  Google Scholar 

  20. Machens A, Ukkat J, Hauptmann S, Dralle H (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg 142:289–293

    Article  PubMed  CAS  Google Scholar 

  21. Miccoli P, Minuto MN, Ugolini C, Molinaro E, Basolo F, Berti P, Pinchera A, Elisei R (2007) Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer. Endocr Relat Cancer 14:1099–1105

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden

    Per Bümming, Håkan Ahlman, Bengt Nilsson, Bo Wängberg & Svante Jansson

  2. Department of Pathology, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden

    Ola Nilsson

Authors
  1. Per Bümming
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Håkan Ahlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bengt Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ola Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bo Wängberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Svante Jansson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Per Bümming.

Additional information

None of the authors reported any conflict of interest.

Best of Endocrine Surgery in Europe 2008.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bümming, P., Ahlman, H., Nilsson, B. et al. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?. Langenbecks Arch Surg 393, 699–703 (2008). https://doi.org/10.1007/s00423-008-0375-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-008-0375-6

Keywords

Search

Navigation